Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Mayo Clinic
Boston Pharmaceuticals
SWOG Cancer Research Network
University of Southern California
Yale University
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)